Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon

被引:5
作者
Andoulo, Firmin Ankouane [1 ]
Noah, Dominique Noah [2 ]
Djapa, Roger [1 ]
Kowo, Mathurin [1 ]
Talla, Paul [3 ]
Medjo, Edith Hell [4 ]
Djomkam, Isidore Kamsi [1 ]
Nonga, Bernadette Ngo [5 ]
Njoya, Oudou [1 ]
Ndam, Elie Claude Ndjitoyap [3 ]
机构
[1] Univ Yaounde I, Yaounde Univ Hosp Ctr, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon
[2] Univ Douala, Yaounde Cent Hosp, Fac Med & Pharmaceut Sci, Dept Internal Med & Specialties, Douala, Cameroon
[3] Univ Yaounde I, Yaounde Gen Hosp, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon
[4] Univ Yaounde I, Yaounde Cent Hosp, Fac Med & Biomed Sci, Dept Radiol, Yaounde, Cameroon
[5] Univ Yaounde I, Yaounde Univ Hosp Ctr, Fac Med & Biomed Sci, Dept Surg & Specialties, Yaounde, Cameroon
来源
PAN AFRICAN MEDICAL JOURNAL | 2014年 / 19卷
关键词
Hepatocellular carcinoma; hepatitis C; developing countries; epidemiology; cirrhosis; alcohol; parenteral exposition; Cameroon;
D O I
10.11604/pamj.2014.19.379.4143
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: hepatocellular carcinoma (HCC) is a global public health problem. Hepatitis C virus (HCV) infection accounts for close to 24% of HCC in developing countries especially when associated with cirrhosis. There exists no vaccine against HCV to prevent the occurrence of HCVrelated HCC. A sound knowledge of the epidemiology and prevention of the initial infection is vital. The aim of our study was to determine the epidemiologic profile of HCV- related HCC in Cameroon to improve its' management. Methods: it was a prospective study of histologically proven HCV- related HCC seen in two University Centers in Yaounde, Cameroon from March 2012 to January 2013. Demographic data (age, gender), alcohol abuse (> 80g/day), presence of cirrhosis, tobacco abuse and parenteral exposition were analyzed. Results: twenty- six patients with histologically proven HCV- related HCC were included (18 men (69.2%) and 8 women (30.8%); mean age +/- SD, 61.46+/- 10.18 years). A total of 22 (84.6%) patients had a parenteral exposition, 02 (7.7%) patients were alcoholics and 06 (23.1%) patients were smokers. The proportion of patients with cirrhosis was 69.2% against 30.8% cirrhosis- free. Patients with cirrhosis were relatively younger than those cirrhosis- free (mean age +/- SD, 59.05 +/- 10.05 years vs 66.87+/- 8.72 years, p= 0.06). HCV- related HCC was more prevalent in 60 years and above patients (53.8%, 95% CI: 33.4- 73.4). The relative risk of HCC among alcoholics patients was high (RR: 1.5, 95% CI: 1.13- 1.99, pConclusion: in Cameroon, HCVrelated HCC is more prevalent among age older than 60 years, a finding which is relatively less to that found in western countries, male gender is twice more at risk than female gender and cirrhosis frequency is less compared to that observed elsewhere. HCV and alcohol play a synergistic role in the occurrence of HCC in our environment.
引用
收藏
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 2010, J GASTROENTEROL HEPA, V25, P657
[2]  
But David Yiu-Kuen, 2008, J GASTROENTEROL, V14, P1652
[3]   DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA AMONG PATIENTS WITH CHRONIC LIVER-DISEASE DUE TO HEPATITIS-C VIRAL-INFECTION [J].
DIBISCEGLIE, AM ;
SIMPSON, LH ;
LOTZE, MT ;
HOOFNAGLE, JH .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1994, 19 (03) :222-226
[4]   Epidemiology of hepatocellular carcinoma in USA [J].
El-Serag, Hashem B. .
HEPATOLOGY RESEARCH, 2007, 37 :S88-S94
[5]   Hepatocellular carcinoma in cirrhosis: Incidence and risk factors [J].
Fattovich, G ;
Stroffolini, T ;
Zagni, I ;
Donato, F .
GASTROENTEROLOGY, 2004, 127 (05) :S35-S50
[6]   Incidence rates of hepatocellular carcinoma in the US and Denmark: Recent trends [J].
Jepsen, Peter ;
Vilstrup, Hendrik ;
Tarone, Robert E. ;
Friis, Soren ;
Sorensen, Henrik Toft .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) :1624-1626
[7]   Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India [J].
Kumar, Manoj ;
Kumar, Rakesh ;
Hissar, Syed S. ;
Saraswat, Manoj Kumar ;
Sharma, Barjesh Chander ;
Sakhuja, Puja ;
Sarin, Shiv Kumar .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (07) :1104-1111
[8]   Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations [J].
Lodato, Francesca ;
Mazzella, Giuseppe ;
Festi, Davide ;
Azzaroli, Francesco ;
Colecchia, Antonio ;
Roda, Enrico .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (45) :7239-7249
[9]   Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? [J].
Lok, Anna Suk-Fong .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) :221-227
[10]  
Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4